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Objective: This paper aimed at describing the most consistent correlates and/or predictors of 
nonadherence to treatment of patients with different anxiety disorders.
Method: The authors retrieved studies indexed in PubMed/MedLine, PsycINFO, and ISI Web 
of Knowledge using the following search terms: attrition OR dropout OR attrition rates OR 
patient dropouts OR treatment adherence AND anxiety disorders. Research was limited to 
articles published before January 2010.
Results: Sixteen studies were selected that investigated the impact of sociodemographic, clini-
cal, or cognitive variables on adherence to treatment for anxiety disorders. While no consistent 
pattern of sociodemographic or clinical features associated with nonadherence emerged, all 
studies that investigated cognitive variables in panic disorder, social anxiety disorder, and 
obsessive-compulsive disorder found that expectations and opinions about treatment were 
related to adherence.
Conclusion: The findings of this study suggest that it is essential to consider anxiety disorder 
patients’ beliefs about illness and treatment strategies to increase their compliance with the 
therapeutic plan.
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Introduction
Pathological anxiety and fear, ie, functioning impairing mood states associated with 
preparation for possible or imminent negative events, are the core features of the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision 
(DSM-IV-TR) anxiety disorders. Current conditions subsumed under its epithet include, 
among others, generalized anxiety disorder, obsessive-compulsive disorder (OCD), 
panic disorder, agoraphobia, specific phobias, social anxiety disorder (SAD) or “social 
phobia,” posttraumatic stress disorder, and acute stress disorder.   Epidemiological 
studies show that anxiety disorders are the most common class of mental disorders, 
affecting up to 28.8% of the general population at some point during their lives.1 People 
with anxiety disorders present significant functional and occupational impairments. In 
addition, they use public health services more often, thus leading to greater financial 
expenditures.1,2 These findings illustrate the importance of access to treatment and 
adherence to therapeutic strategies for patients with these conditions.
Although the dropout rate of patients with various psychiatric disorders for treat-
ments in progress is approximately 50%,3–5 the situation for anxiety disorders may 
be particularly problematic. For instance, it has been suggested that up to 85% of 
patients with social phobia who were initially interviewed do not attend follow-up Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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treatment sessions.2 Although no clear information on the 
clinical, functional, and economic impact of treatment drop-
out anxiety disorders is available, the high level of attrition 
compromises the effectiveness of treatment. Identifying the 
risk factors for dropout in patients with anxiety disorders 
would allow clinicians to develop strategies that promote 
higher adherence to an established therapeutic plan (either 
pharmacological or psychosocial).
The objective of this review is to identify the sociodemo-
graphic, clinical, and cognitive variables that predict attrition/
dropout from different DSM-IV anxiety disorder treatments. 
Of note, studies including treatment adherence of patients 
with major depressive disorder with concomitant anxiety 
symptoms were excluded for not describing individuals with 
a primary anxiety disorder. The authors of this present review 
hypothesize that patients with lower socioeconomic levels, 
less education, more comorbidities, and negative beliefs or 
expectations regarding treatment will be more likely to drop 
out before completion compared with those without these 
characteristics.
Methods
The authors of this review identified studies that investigated 
predictors of attrition/dropout for anxiety disorder treatments 
through searches on PubMed/MedLine, PsycInfo, and ISI 
Web of Knowledge. The following search terms were used: 
attrition OR dropout OR attrition rates OR patient dropouts 
OR treatment adherence AND anxiety disorders. Research 
was restricted to articles published before January 2010. 
  Additionally, the references of the selected studies were exam-
ined to find others related to the subject matter of interest.
Studies that investigated adherence to pharmacological, 
psychological, or both types of treatment in adults with a 
primary diagnosis of anxiety disorder were included. The 
studies that were included evaluated both the absence of 
treatment adherence after the initial interview but before 
the treatment had begun (ie, attrition) and the absence of 
treatment adherence after the treatment had begun (ie, 
“  dropout”). Studies addressing attrition or dropout in 
randomized controlled trials, open studies, naturalistic 
follow-ups, and retrospective assessments were included. 
Excluded studies were those that (1) focused on appraising 
the attrition or dropout of treatment in patients with pri-
mary major depression associated with secondary anxiety, 
(2) described the index of attrition or dropout but did not 
evaluate its predictors, (3) investigated predictors of attrition 
or dropout in children or adolescents with anxiety disorders, 
and (4) included qualitative methods.
Results
A MedLine search resulted in 287 studies, of which 10 met 
the inclusion criteria. A PsycInfo search found 304 stud-
ies, of which two satisfied the inclusion criteria; however, 
these studies had already been selected in the MedLine 
search. Finally, an ISI Web of Knowledge search resulted 
in 318 articles, of which five met inclusion criteria, four of 
which had already been identified in the MedLine search. 
Another five relevant articles were found in the references of 
these studies that had not appeared in the database searches. 
Thus, a total of 16 articles were selected. A psychologist and 
a psychiatrist evaluated all of these articles jointly.
The data were organized into two subsections. The first 
part (Studies’ designs) addressed the informative value of 
the reviewed studies, while the second one (Studies’ results) 
described the results that can be inferred from these studies. 
The first subsection included tables listing studies that inves-
tigated treatment adherence in anxiety disorders in general 
(Table 1), in panic disorder (Table 2), in SAD (Table 3), and 
in OCD (Table 4), their sample sizes, the type of treatments 
they offered and/or were applied, the instruments that were 
employed, the attrition and dropout treatment indices, and the 
cognitive, clinical, and sociodemographic variables that pre-
dicted these features. The second subsection included one table 
(Table 5) describing the results associated with each potential 
predictor. This latter table describes the potential predictor, the 
number of studies investigating it, and the number of studies 
reporting a positive or negative association with adherence.
Studies’ designs
A total of 16,766 patients with anxiety disorders were 
assessed with regard to treatment adherence, including 
13,085 patients from a single retrospective study using a large 
managed care database. The impact of sociodemographic, 
clinical, and cognitive variables on adherence to treatment 
was evaluated in 14, 15, and seven studies, respectively. 
Seven papers assessed adherence to treatment in randomized 
controlled trials, six in naturalistic studies, three in open stud-
ies, and one in a retrospective study. One study combined data 
from an open and a controlled trial in a single analysis.
Most (12) studies assessed adherence to cognitive 
behavioral therapies, eight studies evaluated adherence to 
pharmacotherapy, and three investigated adherence to the 
combined treatment. Three papers included assessment of 
the three forms of treatment (pharmacotherapy, cognitive 
behavioral, or combined treatments). Treatment included 
serotonin reuptake inhibitors in four and individual   cognitive 
behavioral treatment in five studies. Statistical analysis Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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s
e
 
 
a
t
t
i
t
u
d
e
s
 
w
e
r
e
 
l
e
s
s
 
f
a
v
o
r
a
b
l
e
 
 
t
o
 
t
h
e
i
r
 
s
p
e
c
i
fi
c
 
t
r
e
a
t
m
e
n
t
,
 
a
n
d
 
 
w
h
o
 
p
r
e
s
e
n
t
e
d
 
a
 
c
o
p
i
n
g
 
s
t
y
l
e
 
 
f
o
r
 
a
n
x
i
o
u
s
 
s
i
t
u
a
t
i
o
n
s
 
b
a
s
e
d
 
 
o
n
 
t
h
e
 
s
e
a
r
c
h
 
f
o
r
 
s
o
c
i
a
l
 
s
u
p
p
o
r
t
 
 
i
n
 
a
c
c
o
r
d
a
n
c
e
 
w
i
t
h
 
r
e
s
p
o
n
s
e
s
 
 
t
o
 
t
h
e
 
w
C
C
L
 
a
d
h
e
r
e
d
 
l
e
s
s
 
 
t
h
a
n
 
t
h
o
s
e
 
w
i
t
h
o
u
t
 
t
h
e
s
e
 
 
c
o
n
d
i
t
i
o
n
s
.
H
o
f
m
a
n
n
 
 
e
t
 
a
l
1
8
C
o
n
t
r
o
l
l
e
d
 
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
6
2
8
C
B
T
 
 
(
i
e
,
 
p
a
n
i
c
 
c
o
n
t
r
o
l
 
t
h
e
r
a
p
y
)
,
 
 
i
m
i
p
r
a
m
i
n
e
,
 
c
o
m
b
i
n
e
d
 
 
t
r
e
a
t
m
e
n
t
s
,
 
o
r
 
p
l
a
c
e
b
o
.
A
D
i
S
-
R
 
a
n
d
 
 
S
C
i
D
4
8
.
6
%
 
 
a
t
t
r
i
t
i
o
n
N
o
t
 
e
v
a
l
u
a
t
e
d
N
o
t
 
e
v
a
l
u
a
t
e
d
P
a
t
i
e
n
t
s
 
w
h
o
 
d
i
d
 
n
o
t
 
w
a
n
t
 
 
t
o
 
t
a
k
e
 
o
r
 
i
n
t
e
r
r
u
p
t
 
t
h
e
i
r
 
 
c
u
r
r
e
n
t
 
m
e
d
i
c
a
t
i
o
n
 
a
d
h
e
r
e
d
 
 
l
e
s
s
 
t
h
a
n
 
t
h
o
s
e
 
w
h
o
 
w
e
r
e
 
 
w
i
l
l
i
n
g
 
t
o
 
d
o
 
s
o
.
K
e
i
j
s
e
r
s
 
 
e
t
 
a
l
1
7
O
p
e
n
 
s
t
u
d
y
1
6
1
C
B
T
 
 
(
p
a
n
i
c
 
c
o
n
t
r
o
l
 
t
h
e
r
a
p
y
)
N
M
L
-
2
,
 
P
D
Q
-
R
,
 
 
A
C
Q
,
 
a
n
d
 
M
i
1
9
.
9
%
 
 
d
r
o
p
o
u
t
A
b
s
e
n
t
P
a
t
i
e
n
t
s
 
w
i
t
h
 
l
e
s
s
 
e
d
u
c
a
t
i
o
n
 
 
a
d
h
e
r
e
d
 
l
e
s
s
 
t
h
a
n
 
t
h
o
s
e
 
 
w
i
t
h
 
m
o
r
e
 
e
d
u
c
a
t
i
o
n
.
P
a
t
i
e
n
t
s
 
w
h
o
 
w
e
r
e
 
l
e
s
s
 
 
m
o
t
i
v
a
t
e
d
 
a
d
h
e
r
e
d
 
l
e
s
s
 
t
h
a
n
 
 
t
h
o
s
e
 
w
h
o
 
w
e
r
e
 
m
o
r
e
 
 
m
o
t
i
v
a
t
e
d
.
T
o
n
i
 
 
e
t
 
a
l
5
N
a
t
u
r
a
l
i
s
t
i
c
 
 
s
t
u
d
y
3
2
6
i
m
i
p
r
a
m
i
n
e
,
 
c
l
o
m
i
p
r
a
m
i
n
e
,
 
 
o
r
 
p
a
r
o
x
e
t
i
n
e
S
C
i
D
,
 
P
D
A
i
,
 
a
n
d
 
 
L
i
F
e
-
U
P
5
4
.
9
%
 
 
d
r
o
p
o
u
t
L
e
s
s
 
s
e
v
e
r
e
 
i
l
l
n
e
s
s
 
r
e
d
u
c
e
d
 
t
r
e
a
t
m
e
n
t
 
a
d
h
e
r
e
n
c
e
.
A
b
s
e
n
t
N
o
t
 
e
v
a
l
u
a
t
e
d
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
C
B
T
,
 
c
o
g
n
i
t
i
v
e
-
b
e
h
a
v
i
o
r
 
t
h
e
r
a
p
y
;
 
A
D
i
S
-
R
:
 
A
n
x
i
e
t
y
 
D
i
s
o
r
d
e
r
s
 
i
n
t
e
r
v
i
e
w
 
S
c
h
e
d
u
l
e
-
R
e
v
i
s
e
d
;
 
M
i
,
 
M
o
b
i
l
i
t
y
 
i
n
v
e
n
t
o
r
y
;
 
S
T
A
i
,
 
S
t
a
t
e
-
T
r
a
i
t
 
A
n
x
i
e
t
y
 
i
n
v
e
n
t
o
r
y
;
 
B
A
i
,
 
B
e
c
k
 
A
n
x
i
e
t
y
 
i
n
v
e
n
t
o
r
y
;
 
B
D
i
,
 
B
e
c
k
 
D
e
p
r
e
s
s
i
o
n
 
i
n
v
e
n
t
o
r
y
;
 
A
C
Q
,
 
A
g
o
r
a
p
h
o
b
i
c
 
C
o
g
n
i
t
i
o
n
s
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
B
S
Q
,
 
B
o
d
y
 
S
e
n
s
a
t
i
o
n
s
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
D
A
S
,
 
D
y
a
d
i
c
 
A
d
j
u
s
t
m
e
n
t
 
S
c
a
l
e
;
 
M
C
I
C
,
 
M
o
d
i
fi
e
d
 
C
o
u
p
l
e
s
 
I
n
t
e
r
a
c
t
i
o
n
 
C
h
e
c
k
l
i
s
t
;
 
T
N
Q
,
 
T
r
e
a
t
m
e
n
t
 
N
o
n
-
c
o
m
p
l
e
t
e
r
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
A
T
T
,
 
A
t
t
i
t
u
d
e
s
 
T
o
w
a
r
d
 
T
r
e
a
t
m
e
n
t
;
 
A
S
i
,
 
T
h
e
 
A
n
x
i
e
t
y
 
S
e
n
s
i
t
i
v
e
 
i
n
d
e
x
;
 
H
M
A
,
 
H
a
m
i
l
t
o
n
 
A
n
x
i
e
t
y
 
R
a
t
i
n
g
 
S
c
a
l
e
;
 
H
M
D
,
 
H
a
m
i
l
t
o
n
 
R
a
t
i
n
g
 
S
c
a
l
e
 
f
o
r
 
D
e
p
r
e
s
s
i
o
n
;
 
P
A
e
Q
,
 
P
a
t
i
e
n
t
s
’
 
A
t
t
i
t
u
d
e
s
 
a
n
d
 
e
x
p
e
c
t
a
t
i
o
n
s
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
e
M
Q
,
 
e
t
i
o
l
o
g
i
c
a
l
 
M
o
d
e
l
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
w
C
C
L
,
 
T
h
e
 
w
a
y
s
 
o
f
 
C
o
p
i
n
g
 
C
h
e
c
k
l
i
s
t
;
 
S
C
i
D
,
 
S
t
r
u
c
t
u
r
e
d
 
C
l
i
n
i
c
a
l
 
i
n
t
e
r
v
i
e
w
 
f
o
r
 
D
S
M
-
i
i
i
-
R
;
 
P
D
A
i
,
 
P
a
n
i
c
 
D
i
s
o
r
d
e
r
-
A
g
o
r
a
p
h
o
b
i
c
 
i
n
t
e
r
v
i
e
w
;
 
L
i
F
e
-
U
P
,
 
L
o
n
g
i
t
u
d
i
n
a
l
 
i
n
t
e
r
v
i
e
w
 
F
o
l
l
o
w
-
u
p
 
e
x
a
m
i
n
a
t
i
o
n
;
 
N
M
L
-
2
,
 
N
i
j
m
e
g
e
n
 
M
o
t
i
v
a
t
i
o
n
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
-
2
;
 
P
D
Q
-
R
,
 
P
e
r
s
o
n
a
l
i
t
y
 
D
i
a
g
n
o
s
t
i
c
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
-
R
e
v
i
s
e
d
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Treatment adherence in anxiety
T
a
b
l
e
 
3
 
S
t
u
d
i
e
s
 
t
h
a
t
 
i
n
v
e
s
t
i
g
a
t
e
 
t
r
e
a
t
m
e
n
t
 
a
d
h
e
r
e
n
c
e
 
i
n
 
p
a
t
i
e
n
t
s
 
w
i
t
h
 
S
A
D
S
t
u
d
y
D
e
s
i
g
n
N
T
y
p
e
 
o
f
 
t
r
e
a
t
m
e
n
t
I
n
s
t
r
u
m
e
n
t
A
t
t
r
i
t
i
o
n
/
d
r
o
p
o
u
t
 
r
a
t
e
C
l
i
n
i
c
a
l
 
p
r
e
d
i
c
t
o
r
s
 
 
o
f
 
a
d
h
e
r
e
n
c
e
S
o
c
i
o
d
e
m
o
g
r
a
p
h
i
c
 
p
r
e
d
i
c
t
o
r
s
 
o
f
 
 
a
d
h
e
r
e
n
c
e
C
o
g
n
i
t
i
v
e
 
 
p
r
e
d
i
c
t
o
r
s
 
o
f
 
a
d
h
e
r
e
n
c
e
T
u
r
n
e
r
 
e
t
 
a
l
1
5
C
o
n
t
r
o
l
l
e
d
 
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
8
4
B
e
h
a
v
i
o
r
a
l
 
t
h
e
r
a
p
y
 
 
(
i
e
,
 
i
n
u
n
d
a
t
i
o
n
)
,
 
a
t
e
n
o
l
o
l
,
 
 
o
r
 
p
l
a
c
e
b
o
 
p
i
l
l
A
D
i
S
-
R
,
 
S
C
i
D
-
i
i
,
 
S
P
A
i
,
 
 
S
A
D
S
,
 
F
N
e
,
 
F
Q
,
 
S
T
A
i
;
 
 
H
M
A
,
 
C
G
i
,
 
S
U
D
S
,
 
a
n
d
 
 
S
i
S
T
1
5
.
5
%
 
a
t
t
r
i
t
i
o
n
 
 
a
n
d
 
1
2
.
7
%
 
 
d
r
o
p
o
u
t
P
a
t
i
e
n
t
s
 
w
i
t
h
 
l
o
w
e
r
 
c
l
i
n
i
c
a
l
 
 
s
e
v
e
r
i
t
y
 
s
c
a
l
e
 
s
c
o
r
e
s
 
a
n
d
 
 
f
u
n
c
t
i
o
n
a
l
 
l
e
v
e
l
s
 
o
n
 
t
h
e
 
 
A
D
i
S
-
R
 
a
d
h
e
r
e
d
 
l
e
s
s
 
i
n
 
 
t
h
e
 
p
r
e
-
t
r
e
a
t
m
e
n
t
 
p
h
a
s
e
 
 
c
o
m
p
a
r
e
d
 
w
i
t
h
 
t
h
o
s
e
 
 
w
i
t
h
o
u
t
 
t
h
e
s
e
 
q
u
a
l
i
t
i
e
s
.
 
 
D
u
r
i
n
g
 
t
r
e
a
t
m
e
n
t
,
 
p
a
t
i
e
n
t
s
 
 
w
h
o
 
h
a
d
 
l
o
w
e
r
 
d
i
s
e
a
s
e
 
 
s
e
v
e
r
i
t
y
 
s
c
o
r
e
s
 
o
n
 
t
h
e
 
S
T
A
i
 
 
a
d
h
e
r
e
d
 
l
e
s
s
 
t
h
a
n
 
p
a
t
i
e
n
t
s
 
 
w
i
t
h
 
h
i
g
h
e
r
 
s
c
o
r
e
s
.
A
b
s
e
n
t
N
o
t
 
e
v
a
l
u
a
t
e
d
C
o
l
e
s
 
e
t
 
a
l
2
C
o
n
t
r
o
l
l
e
d
 
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
 
 
a
n
d
 
o
p
e
n
 
s
t
u
d
y
3
9
5
C
B
T
 
i
n
 
g
r
o
u
p
,
 
p
h
e
n
e
l
z
i
n
e
 
 
o
r
 
p
l
a
c
e
b
o
 
a
n
d
 
C
B
T
 
 
i
n
 
g
r
o
u
p
A
D
i
S
-
i
v
-
L
,
 
G
A
F
,
 
 
B
F
N
e
,
 
S
i
A
S
,
 
S
P
S
,
 
B
D
i
,
 
 
L
S
R
D
S
,
 
a
n
d
 
Q
O
L
i
8
5
.
0
%
 
a
t
t
r
i
t
i
o
n
A
b
s
e
n
t
A
b
s
e
n
t
N
o
t
 
e
v
a
l
u
a
t
e
d
H
o
f
m
a
n
n
 
a
n
d
 
S
u
v
a
k
1
6
C
o
n
t
r
o
l
l
e
d
 
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
1
3
3
B
e
h
a
v
i
o
r
a
l
 
t
h
e
r
a
p
y
 
i
n
 
 
g
r
o
u
p
 
(
i
e
,
 
l
i
v
e
 
e
x
p
o
s
u
r
e
,
 
 
v
i
d
e
o
 
f
e
e
d
b
a
c
k
,
 
a
n
d
 
 
i
n
s
t
r
u
c
t
i
v
e
 
t
r
a
i
n
i
n
g
;
 
C
B
T
 
 
i
n
 
g
r
o
u
p
 
(
i
e
,
 
c
o
g
n
i
t
i
v
e
 
 
r
e
s
t
r
u
c
t
u
r
i
n
g
 
a
n
d
 
 
e
x
p
o
s
u
r
e
)
.
A
D
i
S
-
i
v
,
 
S
P
A
i
,
 
B
D
i
,
 
 
a
n
d
 
P
D
Q
-
i
v
2
5
.
6
%
 
d
r
o
p
o
u
t
A
b
s
e
n
t
A
b
s
e
n
t
P
a
t
i
e
n
t
s
 
w
h
o
 
 
c
o
n
s
i
d
e
r
e
d
 
t
h
e
 
 
t
r
e
a
t
m
e
n
t
 
t
o
 
b
e
 
 
l
e
s
s
 
l
o
g
i
c
a
l
 
 
a
d
h
e
r
e
d
 
l
e
s
s
 
t
h
a
n
 
 
t
h
o
s
e
 
w
h
o
 
d
i
d
 
n
o
t
 
 
s
h
a
r
e
 
t
h
i
s
 
t
h
o
u
g
h
t
.
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
C
B
T
,
 
c
o
g
n
i
t
i
v
e
-
b
e
h
a
v
i
o
r
 
t
h
e
r
a
p
y
;
 
S
A
D
,
 
s
o
c
i
a
l
 
a
n
x
i
e
t
y
 
d
i
s
o
r
d
e
r
;
 
A
D
i
S
-
R
,
 
A
n
x
i
e
t
y
 
D
i
s
o
r
d
e
r
s
 
i
n
t
e
r
v
i
e
w
 
S
c
h
e
d
u
l
e
-
R
e
v
i
s
e
d
;
 
M
i
,
 
M
o
b
i
l
i
t
y
 
i
n
v
e
n
t
o
r
y
;
 
S
T
A
i
,
 
S
t
a
t
e
-
T
r
a
i
t
 
A
n
x
i
e
t
y
 
i
n
v
e
n
t
o
r
y
;
 
B
D
i
,
 
B
e
c
k
 
D
e
p
r
e
s
s
i
o
n
 
i
n
v
e
n
t
o
r
y
;
 
H
M
A
,
 
H
a
m
i
l
t
o
n
 
A
n
x
i
e
t
y
 
R
a
t
i
n
g
 
S
c
a
l
e
;
 
S
C
i
D
,
 
S
t
r
u
c
t
u
r
e
d
 
C
l
i
n
i
c
a
l
 
i
n
t
e
r
v
i
e
w
 
f
o
r
 
D
S
M
-
i
i
i
-
R
;
 
P
D
Q
-
R
,
 
P
e
r
s
o
n
a
l
i
t
y
 
D
i
a
g
n
o
s
t
i
c
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
-
R
e
v
i
s
e
d
;
 
S
A
D
S
,
 
S
o
c
i
a
l
 
A
v
o
i
d
a
n
c
e
 
a
n
d
 
D
i
s
t
r
e
s
s
 
S
c
a
l
e
;
 
F
N
e
,
 
F
e
a
r
 
o
f
 
N
e
g
a
t
i
v
e
 
e
v
a
l
u
a
t
i
o
n
 
S
c
a
l
e
;
 
F
Q
,
 
F
e
a
r
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
C
G
i
,
 
C
l
i
n
i
c
a
l
 
G
l
o
b
a
l
 
i
m
p
r
e
s
s
i
o
n
;
 
S
U
D
S
,
 
S
u
b
j
e
c
t
i
v
e
 
U
n
i
t
s
 
o
f
 
D
i
s
t
r
e
s
s
 
S
c
a
l
e
;
 
S
i
S
T
,
 
S
o
c
i
a
l
 
i
n
t
e
r
a
c
t
i
o
n
 
S
e
l
f
-
S
t
a
t
e
m
e
n
t
 
T
e
s
t
;
 
A
D
i
S
-
i
v
-
L
,
 
A
n
x
i
e
t
y
 
D
i
s
o
r
d
e
r
s
 
i
n
t
e
r
v
i
e
w
 
S
c
h
e
d
u
l
e
 
f
o
r
 
D
S
M
-
i
v
-
L
i
f
e
t
i
m
e
 
v
e
r
s
i
o
n
;
 
G
A
F
,
 
T
h
e
 
G
l
o
b
a
l
 
A
s
s
e
s
s
m
e
n
t
 
o
f
 
F
u
n
c
t
i
o
n
i
n
g
;
 
B
F
N
e
,
 
T
h
e
 
B
r
i
e
f
 
F
e
a
r
 
o
f
 
N
e
g
a
t
i
v
e
 
e
v
a
l
u
a
t
i
o
n
 
S
c
a
l
e
;
 
S
i
A
S
,
 
T
h
e
 
S
o
c
i
a
l
 
i
n
t
e
r
a
c
t
i
o
n
 
A
n
x
i
e
t
y
 
S
c
a
l
e
;
 
S
P
S
,
 
S
o
c
i
a
l
 
P
h
o
b
i
a
 
S
c
a
l
e
;
 
L
S
R
D
S
,
 
T
h
e
 
L
i
e
b
o
w
i
t
z
 
S
e
l
f
-
R
a
t
e
d
 
D
i
s
a
b
i
l
i
t
y
 
S
c
a
l
e
;
 
Q
O
L
i
,
 
Q
u
a
l
i
t
y
 
o
f
 
L
i
f
e
 
i
n
v
e
n
t
o
r
y
;
 
S
P
A
i
,
 
S
o
c
i
a
l
 
P
h
o
b
i
a
 
a
n
d
 
A
n
x
i
e
t
y
 
i
n
v
e
n
t
o
r
y
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Table 5 Sociodemographic, clinical, and cognitive predictors of treatment adherence in anxiety disorders and the number of studies 
assessing them
Potential  
predictor
Number  
of studies
Positive correlation  
with dropout/attrition
Negative correlation  
with dropout/attrition
Sociodemographic aspects
Anxiety disorders in general Age 14 1 –
Female sex 14 1 –
education level 9 1 3
Lower socioeconomic level 6 1 1
Clinical aspects
Anxiety disorders in general Severity of anxiety symptoms 3 – 1
Comorbidities 3 1 1
Personality factors 2 1 –
Panic disorder Severity of panic symptoms 4 1 1
Comorbidities 2 – –
Personality factors 3 – –
SAD Severity of SAD symptoms 3 – 1
Comorbidities 3 – –
Personality factors 2 – –
OCD Severity of OCD symptoms 4 2 1
Comorbidities 2 1 1
Personality factors 1 – –
Cognitive aspects
Panic disorder 4 4 –
SAD 1 1 –
OCD 2 2 –
Abbreviations: OCD, obsessive-compulsive disorder; SAD, social anxiety disorder.
also varied greatly, but most studies used chi-square tests, 
regression analysis, and correlations to find the predictors 
(or correlates) of adherence.
Studies’ results
A summary of findings, describing different classes of socio-
demographic, clinical, and cognitive predictors of treatment 
adherence, is depicted in Table 5, along with the number of 
studies assessing each dimension and the number of studies 
showing a positive and negative association between each 
predictor and treatment adherence. Of note, for the sake of 
clarity, the data on sociodemographic aspects of different 
anxiety disorders and the severity of key anxiety symptoms, 
comorbidities, and personality factors have been collapsed 
into single variables for each anxiety disorder.
Sociodemographic variables
Age
Fourteen studies attempted to evaluate the impact of par-
ticipants’ age on treatment adherence.2,4–16 Coles et al2 
investigated the pre-treatment phase of a trial of group 
cognitive-behavior therapy (CBT), phenelzine, and placebo 
for SAD. They found that these patients displayed a high pre-
treatment attrition rate (85%) and that older patients turned 
down treatment more often than younger ones.
Sex
The same studies assessed the impact of participants’ sex on 
treatment adherence.2,4–16
Among these studies, Issakidis and Andrews4 studied 
patients with various anxiety disorders and found that women 
dropped out of CBT more frequently than men.
education level
Nine studies investigated the influence of education 
level on treatment adherence in patients with anxiety 
disorders.2,4,6,11,13–17 Of these studies, four found significant 
results.2,6,13,17 In a univariate analysis, Grilo et al6 found that 
patients with panic disorder who dropped out of a treatment 
trial comparing CBT, imipramine, and placebo had less 
education than those who completed treatment. However, a 
multivariate regression that controlled for other variables (eg, 
sociodemographic characteristics, severity of panic disorder, 
psychiatric comorbidity, attitude toward treatment, coping 
style, and personality style) found that educational level did 
not significantly contribute to dropouts, unlike family income 
and participant age.
In the Coles et al2 SAD study, treatment-seeking people 
with less education, who were non-Caucasian and either 
unemployed or employed fulltime, were significantly more 
likely to schedule, but not attend, an initial interview. Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
434
Santana and Fontenelle
  Furthermore, Coles et al2 conducted a logistic regression to 
determine the extent to which demographic variables deter-
mined interview attendance. A model that included race, 
age, and level of education explained 70.7% of the variance 
of treatment adherence.
Keijsers et al17 studied 161 patients with panic disorder 
and also found that educational level predicted treatment 
adherence to CBT (panic control therapy). They found that 
less education was associated with dropping out of treatment. 
Although educational level did not emerge as a predictor in a 
univariate analysis, a regression model that included motiva-
tion found that educational level was significantly associated 
with dropping out of treatment.
Unlike the studies above, Santana et al13 conducted a 
naturalistic follow-up study on 223 patients with OCD at a 
university clinic for anxiety disorders that offered free phar-
macological treatment. In that study, the follow-up time of 
the patients (up to 10 years) was considered to be a measure 
of treatment adherence. Through a logistic regression, the 
authors of that study found that patients with less education 
remained in treatment longer.
Socioeconomic level
Seven studies investigated socioeconomic level, includ-
ing family income and employment status.2,4,6,7,13,16 Two 
studies found significant differences between adherent 
and nonadherent patients in terms of socioeconomic 
levels.6,13 As previously described, Grilo et al6 found that 
panic disorder patients who dropped out of a treatment 
trial comparing CBT, imipramine, and placebo presented 
a significantly lower income than patients who continued 
treatment. These findings were detected with regression 
models. On the other hand, Santana et al13 used a linear 
regression model to find that unemployed OCD patients 
remained in treatment longer at a public service compared 
with those with jobs.
Other sociodemographic variables
Santana et al13 examined 223 patients with OCD and found 
a relationship between the patients’ places of residence and 
treatment adherence. Patients who lived in the city where 
the clinic was located remained in treatment longer than 
those who lived in a different city. Issakidis and Andrews4 
used regression models to observe that patients with differ-
ent anxiety disorders who had at least one child and who 
were treated at a general clinic rather than by a specialist 
in a mental health clinic were more likely to turn down the 
pre-treatment phase of CBT.
Similarly, in a study on adherence to   pharmacological 
treatments in 13,085 patients with anxiety disorders, 
Stein et al9 observed that patients who were treated by a 
mental health specialist adhered to treatment more than those 
who were not seen by a specialist. Finally, Grilo et al6 found 
that panic disorder patients with a history of previous and 
brief treatments, defined by a Likert scale varying from 1 (no 
previous treatment) to 4 (more than a year of treatment), were 
more susceptible to dropping out from a controlled treatment 
trial with CBT, imipramine, and placebo compared with 
patients without this history.
Clinical variables
Anxiety disorders in general
Hunt and Andrews8 investigated 1045 patients who sought 
CBT for anxiety disorders from 1986 to 1988. Of these 
patients, 546 met the diagnostic criteria of panic disorder, 
agoraphobia, SAD, and generalized anxiety disorder. Of 
these patients, 432 patients accepted treatment. The clinical 
variables investigated were diagnosis, the severity of psy-
chiatric symptom scale score (Symptoms Checklist-90 or 
SCL-90), the locus of behavioral control scale score and the 
Eysenck Personality Inventory (EPI) neuroticism subscale 
score. There were no significant differences found between 
the group who completed treatment (n = 357) and those who 
dropped out of treatment (n = 75).
Wingerson et al7 hypothesized that personality factors 
might contribute to dropping out of treatment. They inves-
tigated 112 patients with anxiety disorders treated with 
pharmacotherapy (including 5-hydroxytryptamine (5HT) 
reuptake blockers, benzodiazepines, and 5HT1A agonists). 
For panic disorder and generalized anxiety disorder patients 
combined, early dropouts scored higher on total novelty 
seeking of the Tridimensional Personality Questionnaire, as 
well as on the novelty-seeking traits of both disorderliness/
dislike of regimentation and impulsiveness. Patients who 
dropped out of treatment (40%) did not differ from those 
who remained with regard to history of depression, alcohol 
or drug abuse, psychiatric hospitalization, attempted suicide, 
or symptom severity.
Issakidis and Andrews4 investigated 731 patients who 
sought and received treatment in a clinic specialized in 
anxiety disorders. To analyze the data, they defined two 
dependent variables: attrition in pre-treatment (either refusal 
of treatment or nonappearance) and dropping out of treat-
ment once it has started. They analyzed primary psychiatric 
diagnosis, severity of symptoms, psychiatric comorbidities, 
and degree of incapacity. Attrition at pre-treatment (30.4%) Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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was associated with primary diagnosis because patients with 
depression or another psychiatric disorder were more likely 
to turn down treatment compared with those with panic 
  disorder. In addition, the presence of more severe depressive 
symptoms at the initial interview and selection for group 
(rather than individual) treatment also significantly predicted 
attrition. In total, 10.3% of patients dropped out of treatment, 
and as in the pre-treatment phase, patients with comorbid 
depression or depressive symptoms dropped out of treatment 
more often than those without these symptoms. Dropouts 
also reported less severe symptoms before treatment but a 
greater impairment of physical health.
Stein et al9 examined patients with various anxiety 
disorders who were offered pharmacological treatments 
and found divergent results from those of Issakidis and 
Andrews.4 According to Stein et al,9 patients with comorbid 
depression adhered to antidepressants (5HT and serotonin-
noradrenaline reuptake blockers) more than those without 
such a comorbidity. They argued that a possible reason for 
the lower rates of adherence in the nondepressed group was 
the lower likelihood of mental health specialty care within 
this population. In their analysis,9 significantly fewer patients 
with anxiety alone, compared with patients with comorbid 
depression, received mental health specialty care during the 
year after treatment initiation.
In summary, studies that investigated anxiety disorders in 
general differed from each other with regard to their method-
ologies and results. The prevalence of dropouts varied from 
10.3% to 57.0%. Only one study investigated attrition during 
pre-treatment.4 All of the studies investigated the impact of 
comorbidities and the severity of symptoms4,7–9 in adherence. 
However, only two studies4,9 found significant differences 
between adherent and nonadherent patients, with divergent 
results. Specifically, one study found that patients with comor-
bid depression were more likely to turn down pre-treatment 
and drop out from treatment4 compared with patients without 
comorbidities, whereas another study found that patients with 
comorbid depression were more likely to adhere to treatment.9
Panic disorder
Carter et al11 investigated 31 patients with panic disorder and 
agoraphobia who were offered group CBT. The patients’ 
partners accompanied them to each session. The clinical vari-
ables investigated were the number of situations avoided and 
the severity of their panic disorder; however, no significant 
differences were found through a multivariate analysis.
Grilo et al6 investigated 162 patients diagnosed with panic 
disorder, with or without agoraphobia, who were offered 
CBT, medication, or both. They investigated six domains of 
variables: sociodemographic characteristics, severity of panic 
disorder, psychiatric comorbidities, attitude toward treat-
ment, coping style, and personality style. After conducting 
multivariate regressions, the authors of that study verified 
that patients with higher Anxiety Sensitivity Index (ASI) 
scores and low agoraphobic avoidance were more likely to 
discontinue treatment.
As in the study above, Keijsers et al17 investigated 161 
patients with panic disorder who were offered CBT. The 
clinical variables investigated were the severity of symp-
toms and dysfunctional personality traits. The severity of 
symptoms was evaluated through three characteristics: 
catastrophic agoraphobic cognition, agoraphobic avoid-
ance behavior, and the frequency of panic attacks via the 
Agoraphobic Cognitions Questionnaire and the Mobility 
Inventory. Furthermore, these authors of that study evalu-
ated psychopathic personality traits using the Personality 
Diagnostic Questionnaire-Revised to investigate whether 
patients with personality disorders or with higher scores on 
this scale were more likely to discontinue treatment. They 
found no significant differences between dropouts (19.9%) 
and those who completed treatment.
Toni et al5 investigated 326 patients diagnosed with 
panic disorder who were treated with antidepressants and 
followed up for 3 years. During this period, 179 (54.9%) 
patients dropped out of treatment. The only statistically 
significant difference between dropouts and those who 
completed treatment was a lower severity of panic disorder 
among the first group.
To summarize, five studies investigated treatment adher-
ence in patients with panic disorder.5,6,11,17,18 Among this 
sample, four studies5,6,11,17 investigated clinical variables 
related to dropouts in patients with panic disorder and three 
studies included CBT.6,11,17 All of the studies evaluated the 
severity of panic disorder, but only two studies found signifi-
cant findings, and these had divergent results. In one study,6 
patients with a more severe disorder withdrew from treatment 
more often than patients with a less severe disorder, whereas 
the reverse was true in the other study.5 None of these four 
studies5,6,11,17 evaluated attrition in pre-treatment.
SAD
Turner et al15 investigated 84 patients with SAD who 
met the criteria for generalized or circumscribed forms. 
These patients were randomly divided into three groups: 
(1)   exposure, (2) atenolol, and (3) placebo pill. Thirteen 
(15.5%) patients selected for this study declined to participate Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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in the treatment protocol. These patients presented lower 
  severity scores on the Anxiety Diagnostic Interview Schedule 
(ADIS)-Reviewed scale. Among those who participated in 
this study, nine (12.7%) patients dropped out of treatment 
over the course of the 12-week program and differed from 
those who completed treatment in terms of a lower disorder 
severity as measured by the Fear Questionnaire Symptom 
Severity Scale and the Spielberger State-Trait Anxiety 
Inventory self-reports.
Coles et al2 analyzed the treatment course for patients 
with SAD from the initial telephone contact to the begin-
ning of treatment. A total of 395 people made an initial 
telephone call; of these people, only 60 began treatment. 
Thus, 85% of the patients who made initial contact with 
the clinic did not begin treatment. Of the 395 patients who 
contacted the clinic, 131 completed an initial interview. Of 
these patients, 126 people were diagnosed with SAD, and 60 
patients accepted and began treatment. No significant differ-
ences were found between the group who began treatment 
(n = 60) and those who did not (n = 66) with regard to the 
following clinical variables: severity of symptoms, depres-
sive symptoms, quality of life (as measured by the Quality 
of Life Inventory), and functional impairment (as measured 
by the Liebowitz Self-Rated Disability Scale).
Hofmann and Suvak16 also investigated 133 patients 
with SAD who sought group behavioral therapy or group 
CBT in a center for anxiety at Boston University. Of the 133 
patients, 34 (25.6%) dropped out of treatment. The authors 
of that study investigated the following clinical variables: 
DSM-IV Axis-I diagnoses, anxiety and depression scores 
(ie, the Social Phobia and Anxiety Inventory and the Beck 
Depression Inventory, respectively), personality disorders, 
and the index of disease severity stemming from social pho-
bia (as measured by the ADIS for DSM-IV [ADIS-IV]). They 
compared the clinical and sociodemographic variables of the 
group that completed treatment with those of the group who 
dropped out and did not find significant differences.
In summary, all of the studies reviewed here investigated 
the influence of clinical variables on the adherence to treat-
ment for SAD.2,15,16 Two studies2,15 analyzed attrition from 
treatment and obtained different results. Turner et al15 found 
that 15% of patients withdrew from study participation. Coles 
et al2 found that 85% of people who sought clinical help 
withdrew before treatment. This between-study heterogeneity 
may be partially explained by the disparate approaches that 
the studies used to conduct their investigations. Coles et al2 
began their investigation with the first phone call for treat-
ment, whereas Turner et al15 investigated attrition in patients 
who already had a confirmed diagnosis and passed through 
the initial stages of treatment but who ultimately declined 
to participate. Two studies15,16 investigated the patients who 
began treatment and dropped out; however, only one found 
that patients with less severe disease symptoms were more 
likely to discontinue treatment.15
OCD
Hansen et al12 investigated nonadherence to therapy in patients 
with OCD who had undergone CBT. They compared groups 
of 15 dropouts and 15 patients who successfully completed a 
treatment that consisted of 10 sessions of exposure and response 
prevention. Patients who abandoned treatment without inform-
ing their therapist during the study period were considered to be 
nonadherent. The researchers analyzed the severity of OCD as 
measured by the Leyton Obsessional Inventory (LOI) and per-
sonality disorders determined using the Personality Diagnostic 
Questionnaire-Revised. Patients who discontinued treatment 
had lower LOI disease-severity scores.
Mataix-Cols et al10 investigated whether different symp-
tom dimensions in patients with OCD were associated with 
treatment adherence and behavioral therapy response. They 
investigated patients who participated in a controlled clinical 
trial of behavioral therapy either by computer or guided by a 
clinician. They randomly selected 218 patients with OCD to 
receive 10 sessions of treatment for (1) exposure and response 
prevention guided by computer and a manual, (2) exposure 
and response prevention guided by a behavioral therapist, 
and (3) relaxation guided by audiotape. After a 3-month 
follow-up, the patients in the first two groups (exposure by 
computer or therapist) similarly improved, and both groups 
improved more than the relaxation control group. Of the 
patients who received at least one visit for post-evaluation, 
153 completed the Yale-Brown Obsessive-Compulsive Scale 
Checklist (Y-BOCS). The severity of obsessive-compulsive 
symptoms at the beginning of treatment predicted response 
to therapy, and serious symptoms at the outset of therapy 
continued to be more critical at the conclusion of treatment. 
Patients with high scores on the sexual/religious dimension of 
the Y-BOCS had poorer responses to exposure and response 
prevention treatment. Regression analyses revealed that high 
scores on the hoarding dimension predicted dropouts.
Mancebo et al14 validated an instrument (ie, the Treat-
ment Adherence Survey – patient version) that investigates 
adherence to pharmacological and psychological treatments 
in patients with OCD. This instrument is composed of two 
parts. The first section investigates adherence to CBT, and the 
second section investigates adherence to pharmacotherapy. Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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Mancebo et al14 selected 80 patients who participated in the 
Brown Longitudinal OCD Study. Of these patients, 28% did 
not adhere to CBT and 57% did not adhere to medication. 
Those who did not adhere to CBT replied that they felt too 
anxious or fearful to participate in therapy (55%). These 
same patients also had more severe obsessive-compulsive 
and depressive symptoms as evaluated by the Y-BOCS 
and the Modified Hamilton Rating Scale for Depression, 
respectively. Patients who did not adhere to medication more 
frequently reported dissatisfaction with side effects (77%) 
and anxiety or fear with respect to taking medication (41%). 
These patients also had more severe depressive symptoms 
than those who adhered to treatment.
Santana et al13 also investigated patients with OCD 
and, similarly to Hansen et al,12 found results that diverged 
from those of Mancebo et al.14 In this naturalistic study, 
the only clinical variable that predicted adherence was 
comorbid major depression. However, patients who 
presented with this comorbidity were more likely to adhere 
to treatment.
In summary, all the studies that investigated adherence 
to OCD treatment evaluated the impact of the disease’s 
severity.10,12–14 The results were divergent: Hansen et al12 
found that patients with less severe obsessive-compulsive 
symptoms more frequently discontinued treatment, whereas 
Mancebo et al14 found that patients with more severe symp-
toms more frequently dropped out of treatment. Mataix-Cols 
et al10 found that the severity of OCD predicted response 
to treatment but not adherence. One study14 observed that 
patients with comorbid depression and more severe depres-
sive symptoms adhered to treatment less often than those 
without these symptoms, while another one13 described that 
comorbid depression increased adherence.
Cognitive variables
Panic disorder
Carter et al11 asked patients with panic disorder who dropped 
out CBT in group to complete a self-report questionnaire. 
These patients claimed not to have been satisfied with their 
treatment. In addition, they stated that their partner, who 
functioned as their co-therapist and accompanied them to 
all the sessions, did not want them to continue treatment. 
Finally, they declared having “difficulties with the therapy 
sessions.” This last response appeared on a self-report 
questionnaire (Treatment Non-completer Questionnaire) 
that lists 18 common reasons that influence interruptions of 
treatment; however, the authors of the study did not provide 
explanations of these “difficulties.”
Grilo et al6 found significant differences in the attitudes of 
dropout panic disorder patients regarding their treatment and 
the reasons they provided with respect to the etiology of their 
panic attacks. Patients who (1) attributed their panic attacks 
to life stressors, (2) had less favorable attitudes toward their 
treatment (group versus individual treatment), and (3) used 
a coping style based on social support were more likely to 
discontinue treatment.
Hofmann and Suvak16 investigated attrition in patients 
with panic disorder who sought, or were referred to, two 
clinics during the pre-treatment phase. One of the clinics 
offered a pharmacological treatment, whereas the other 
offered a psychological treatment. After an initial interview, 
during which patients were assessed for a formal DSM-IV 
diagnosis of panic disorder, they participated in a study 
that offered five randomly distributed treatment modalities: 
(1) imipramine, (2) panic control (ie, psychological treat-
ment), (3) placebo, (4) imipramine and panic control, and 
(5)   placebo and panic control. The patients were informed 
that they had a 92% chance of receiving an active treatment. 
Of 628 pre-selected patients, 115 were ultimately excluded 
from the study due to diagnosis changes, medical problems, 
or other reasons. Of those eligible for treatment, 305 patients 
(48.6%) refused to participate. The principal reasons given by 
the patients who turned down treatment were that they were 
not willing to take medication (33.8%) or that they were not 
willing to interrupt their usual medication schedule (24.9%). 
The latter reason occurred due to a study regulation in which 
participants were required to interrupt the use of all current 
psychotropic medications.
Keijsers et al17 also found that patients with panic disorder 
who were less motivated for treatment were significantly 
more likely to discontinue treatment. This result appeared in 
both a univariate analysis and a regression model. In addition, 
the authors of that study contacted 25 of the 32 dropouts; 
the most common reasons these former patients provided 
for dropping out included dissatisfaction with CBT and its 
protocol and their improvement to that point, as well as a 
lack of motivation.
SAD
Hofmann and Suvak16 found that SAD patients who discon-
tinued behavioral or group CBT treatment found therapy to 
be less logical than those who completed treatment. A self-
report questionnaire administered after the first session also 
investigated the attitude of the patients toward their treatment. 
Hofmann and Suvak16 tried to contact patients who discon-
tinued treatment, but only 50% responded. Despite a positive Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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correlation between “lack of logic” and the dropout rate, the 
patients reported that they discontinued treatment because of 
conflicts with work, feelings that the group environment was 
overwhelming or that the treatment was ineffective, moving 
to a different city, and personal reasons.
OCD
Hansen et al12 studied patients with OCD after a psychologi-
cal treatment and found similar reasons for dropout using a 
structured questionnaire. Dropouts stated that the therapy 
did not correspond to their expectations and had criticisms 
concerning their therapist. Furthermore, these former patients 
felt less “pressure” from someone close to them to continue 
therapy compared with those who completed treatment. 
These results highlight the importance of knowing and agree-
ing to the proposed treatment, patients’ relationships with 
their therapist, and their attitudes toward treatment.
Mancebo et al14 found that 80 patients with OCD reported 
perceived environmental barriers between CBT and their 
ability to complete treatment. Although there were no expla-
nations of these “environmental barriers,” the fact that the 
patients perceived them as a reason for not adhering to treat-
ment indicates the presence of beliefs with regard to treat-
ment access which must be better investigated. With regard 
to medication adherence, these patients also questioned the 
usefulness of their medication.
Discussion
A total of 16 studies were selected that investigated the 
impact of sociodemographic or clinical variables on adher-
ence to treatment for anxiety disorders. The greatest majority 
of the available studies were unable to find sociodemographic 
differences between adherent and nonadherent patients 
with anxiety disorders. Only one naturalistic study reported 
that women with anxiety disorders discontinued treatment 
more frequently than men.4 Further, in just one study, older, 
non-Caucasian and unemployed anxiety disorder patients 
displayed treatment attrition more frequently than those who 
did not share these features.2 However, in a naturalistic study, 
unemployed OCD patients were more likely to adhere to 
treatment.13 Therefore, it seems that no consistent conclusion 
regarding the effect of gender, age, race, and employment 
on adherence of patients with anxiety disorders to treatment 
can be reached at this moment.
Nine studies2,4,6,11,13–17 investigated the influence of 
education level on treatment adherence of patients with 
anxiety disorders, but only four2,4,13,17 reported significant 
findings. Specifically, three studies found that patients with 
less   education were more likely to turn down treatment,2,4,17 
whereas one study found the opposite result.13 The authors 
of this present review believe that the interpretation of these 
contradictory findings should take into account the peculiari-
ties of each mental health service in question. For instance, 
while greater levels of education could foster adherence to 
a private and/or wealthy clinic, it could also lead to greater 
dropout rates in a public service dedicated to lower income 
individuals.
Further, six studies2,4,6,13,16 investigated the impact of 
socioeconomic levels on treatment adherence in anxiety 
  disorders. Of note, only one study on patients with panic 
disorder found an association between lower socioeconomic 
level and higher likelihoods of dropout,6 while a naturalistic 
study of OCD found a paradoxical association between higher 
socioeconomic levels and greater adherence to treatment.13 In 
the latter study, Santana et al13 tracked patients for 10 years 
via a free university service. Thus, patients with more educa-
tion and higher socioeconomic levels might have sought treat-
ment in private services to avoid some of the inconveniences 
of public services such as lines and hours spent waiting for 
the appointment.
In summary, although there is some evidence that both 
lower educational levels and socioeconomic status can 
adversely affect adherence in anxiety disorders, studies 
showing no relationship outnumber those that do. Also, the 
relationship between adherence to treatment and educational 
levels and socioeconomic status need to be examined in the 
light of the characteristics of the service being provided.
Fifteen studies evaluated the impact of clinical variables 
on dropping out of treatment.2,4–7,8–17 Despite the fact that 
many studies of depression show that comorbidity predicts 
adherence to treatment, the present review revealed that only 
four studies found a relationship between comorbidity and 
treatment adherence. Furthermore, the results were diver-
gent. Stein et al9 and Santana et al13 found that patients with 
comorbid depression adhere to treatment more often than 
those without this comorbidity. In contrast, Issakidis et al4 
and Mancebo et al14 found that patients with comorbid 
depression adhere less to treatment. Thus, our hypothesis 
that comorbidity would predict adherence was not confirmed 
based on studies with depressed patients.
The five studies that investigated cognitive variables 
found similar results and emphasized the importance of treat-
ment choice and favorable attitudes toward treatment.6,11,14,16,18 
Cognitive variables may be an important intervention factor 
because they are more modifiable than clinical and socio-
demographic variables. The results of this review suggest Patient Preference and Adherence
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that treatment programs need to consider these expectations 
and include structured interventions to motivate patients to 
participate in treatment even before it begins.
Conclusion
Few studies have researched correlates or predictors of 
attrition and/or dropout in patients with anxiety disorders. 
The heterogeneity of the findings described in this review 
partially reflects the different methodologies used to identify 
the factors involved in the treatment adherence of patients 
with anxiety disorders. For example, many studies analyzed 
the effects of pharmacological and psychological treatments 
separately, whereas other studies investigated combined 
treatments. Also, given that researchers conceptualize 
“adherence” in different ways, a consensus definition is 
necessary. For example, although some researchers consider 
dropping out to be the cessation of treatment before its offi-
cial conclusion, others consider dropouts to be people who 
continue to attend treatment but do not appear at all of the 
sessions or who take medication less frequently or in smaller 
doses than those prescribed.
Despite this review’s negative findings regarding the 
impact of sociodemographic and clinical features of patients 
with anxiety disorders in treatment adherence, the studies are 
rather consistent in describing a high rate of nonadherence 
among patients with anxiety disorders.9 Thus, the authors 
of this present review emphasize the importance of more 
research on this topic in order to develop strategies that help 
patients conclude their treatments. Furthermore, they empha-
size this review’s consistent results on cognitive variables, 
which indicate that expectations and beliefs about the disease 
and its treatment are important features to be considered in 
the management of patients with anxiety disorders.
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